ARCHIVES

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

BMS Settles Charges Of Obstructing Generics

March 14, 2003

Shared Specimen Resource Needed, GYN Review Finds.

February 1, 2002

Seven Seats Open Up On NCAB

January 17, 1986

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995